Merck, Daiichi reject lung cancer therapy in US (NYSE:MRK) by Technical Terrence Team 06/27/2024 0 JHVEPhoto The US Food and Drug Administration (FDA) has refused to approve an antibody-drug conjugate known as HER3-DXd developed by ...